Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

US Department of Justice
Cantor Fitzgerald
Baxter
Dow
Boehringer Ingelheim
Fish and Richardson
Queensland Health
AstraZeneca
UBS

Generated: October 17, 2018

DrugPatentWatch Database Preview

OXALIPLATIN Drug Profile

« Back to Dashboard

When do Oxaliplatin patents expire, and when can generic versions of Oxaliplatin launch?

Oxaliplatin is a drug marketed by Accord Hlthcare, Actavis Llc, Actavis Totowa, Cipla Ltd, Eugia Pharma, Fresenius Kabi Oncol, Fresenius Kabi Usa, Gland Pharma Ltd, Hospira Inc, Hospira Worldwide, Jiangsu Hengrui Med, Luitpold, Mylan Labs Ltd, Qilu Pharm Co Ltd, Sandoz, Sandoz Inc, Sun Pharma Global, and Teva Pharms. and is included in twenty-five NDAs.

The generic ingredient in OXALIPLATIN is oxaliplatin. There are twenty-six drug master file entries for this compound. Twenty-four suppliers are listed for this compound. There are six tentative approvals for this compound. Additional details are available on the oxaliplatin profile page.

US Patents and Regulatory Information for OXALIPLATIN

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Qilu Pharm Co Ltd OXALIPLATIN oxaliplatin INJECTABLE;IV (INFUSION) 204368-002 Jun 7, 2016 AP RX No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Luitpold OXALIPLATIN oxaliplatin INJECTABLE;IV (INFUSION) 204378-001 May 12, 2017 AP RX No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Sandoz Inc OXALIPLATIN oxaliplatin INJECTABLE;IV (INFUSION) 078812-002 Aug 7, 2009 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Sandoz OXALIPLATIN oxaliplatin INJECTABLE;IV (INFUSION) 090849-001 Apr 28, 2011 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Sun Pharma Global OXALIPLATIN oxaliplatin INJECTABLE;IV (INFUSION) 078818-001 Aug 7, 2009 AP RX No Yes ➤ Sign Up ➤ Sign Up ➤ Sign Up
Teva Pharms OXALIPLATIN oxaliplatin INJECTABLE;IV (INFUSION) 022160-002 Aug 7, 2009 AP RX Yes Yes ➤ Sign Up ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

US Department of Justice
Cantor Fitzgerald
Baxter
Dow
Boehringer Ingelheim
Fish and Richardson
Queensland Health
AstraZeneca
UBS

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.